In2Gen Co., Ltd.

Focus:

Discovery of diagnostics and therapeutics using functional genomics; production of biotechnology medicine using transgenic animals

Company Profile:

In2Gen is a bio venture company and was named for the short form of ‘Into Genome’.

Management:

Dae-kee Kim (CEO)
Yung-jue Bang (CSO)
Kwang-hyun Jeon (CFO)

Address:

6th Floor, Cancer Research Institute, Seoul National University College of Medicine, Yeogun Dong 28, Jongro-Gu, Seoul
Korea
Phone: +82-2-3672-8392, +82-2-3668-7463
Fax: +82-2-3672-8394

E-mail:

in2gen@in2gen.com

Website:

http://in2gen.com

Related patents

Target gene for diagnosis of gastric cancer and development of anticancer drugs identified by cdna microarray analysis and solid support for microarray arraying the same

Information

Service

In2Gen Co., Ltd.

Related patents